References
- Cheda A, Wrembel-Wargocka J, Lisiak E, Nowosielska EM, Marciniak M, Janiak MK. 2004. Single low doses of X-rays inhibit the development of experimental tumor metastases and trigger the activities of NK cells in mice. Radiation Research 161:335–340.
- Clerici M, Shearer GM, Clerici E. 1998. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: Time to consider the TH1/TH2 paradigm. Journal of the National Cancer Institute 90:261–263.
- Cohen BL. 2002. Cancer risk from low-level radiation. American Journal of Roentgenology 179:1137–1143.
- Dunn GP, Old LJ, Schreiber RD. 2004. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137–148.
- Huang P, Taghian A, Allam A, Freeman J, Duffy M, Suit H. 1996. The effect of whole-body irradiation of nude mice on the tumor transplantability and control probability of a human soft tissue sarcoma xenograft. Radiation Research 145:337–342.
- International Commission on Radiological Protection (ICRP). 2006. Low-dose extrapolation of radiation-related cancer risk. Publication 99. Amsterdam: Elsevier.
- Ito M, Shibamoto Y, Ayakawa S, Tomita N, Sugie C, Ogino H. 2008. Effect of low-dose total-body irradiation on transplantability of tumor cells in syngeneic mice. Journal of Radiation Research 49:197–201.
- Little MP, Wakeford R, Tawn EJ, Bouffler SD, de Gonzalez AB. 2009. Risks associated with low doses and low dose rates of ionizing radiation: Why linearity may be (almost) the best we can do. Radiology 251:6–12.
- National Research Council (NRC). 2006. NRC Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. Health risks from low levels of ionizing radiation: BEIR VII, Phase 2. Washington, DC: The National Academies Press.
- Pandey R, Shankar BS, Sharma D, Sainis KB. 2005. Low dose radiation induced immunomodulation: Effect on macrophages and CD8+ T cells. International Journal of Radiation Biology 81:801–812.
- Prasad KN, Cole WC, Hasse GM. 2004. Health risks of low dose ionizing radiation in humans: A review. Experimental Biology and Medicine 229:378–382.
- Swann JB, Smyth MJ. 2007. Immune surveillance of tumors. The Journal of Clinical Investigation 117:1137–1146.
- Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, Schreiber RD, Smyth MJ. 2008. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proceedings of the National Academy of Sciences of the USA 105:652–656.
- Tanaka IB, Tanaka S, Ichinohe K, Matsushita S, Matsumoto T, Otsu H, Oghiso Y, Sato F. 2007. Cause of death and neoplasia in mice continuously exposed to very low dose rates of gamma rays. Radiation Research 167:417–437.
- Tanaka S, Tanaka IB, Sasagawa S, Ichinohe K, Takabatake T, Matsushita S, Matsumoto T, Otsu H, Sato F. 2003. No lengthening of life span in mice continuously exposed to gamma rays at very low dose rates. Radiation Research 160:376–379.
- Tubiana M, Feinendegen LE, Yang C, Kaminski JM. 2009. The linear no-threshold relationship is inconsistent with radiation biologic and experimental data. Radiology 251:13–22.
- Yanagihara K, Nii M, Tsumuraya M, Numoto M, Seito T, Seyama T. 1995. A radiation-induced murine ovarian granulosa cell tumor line: Introduction of v-ras gene potentiates a high metastatic ability. Japanese Journal of Cancer Research 86:347–356.
- Zhu J, Paul WE. 2008. CD4 T cells: Fates, function, and faults. Blood 112:1557–1568.